🔎 Trials Near Me

Hem › Crohns sjukdom › Virginia

Kliniska studier för Crohns sjukdom i Virginia

15 studier för Crohns sjukdom söker deltagare vid platser i Virginia.

Städer i Virginia

Officiell studietext (engelska)

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

  • University of Virginia Health System ( Site 0291), Charlottesville
RekryterarFas 3
Alla åldrar · Alla kön · Uppdaterad 2 okt. 2026 · NCT06651281

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

  • Richmond VA Medical Center ( Site 5021), Richmond
RekryterarFas 3
Ålder 16 till 80 · Alla kön · Uppdaterad 2 okt. 2026 · NCT06430801

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

  • Emeritas Research Group /ID# 284388, Lansdowne Town Center
  • GI Alliance - Richmond /ID# 284244, Richmond
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 2 okt. 2026 · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

  • Gastroenterology Consultants of Southwest Virginia., Roanoke
RekryterarFas 4
Ålder 18 till 80 · Alla kön · Uppdaterad 30 sep. 2026 · NCT06581328

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

  • Gastroenterology Associates of Tidewater, Chesapeake
  • Blue Ridge Medical Research, Lynchburg
RekryterarFas 2/3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07196722

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • VCU Massey Comprehensive Cancer Center, Richmond
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 23 sep. 2026 · NCT03816345

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

  • Blue Ridge Medical Research-Site Number: 8400020, Lynchburg
  • Clinical Research Partners-Site Number: 8400080, Richmond
RekryterarFas 3
Ålder 16 till 80 · Alla kön · Uppdaterad 23 sep. 2026 · NCT07184931

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

  • Gastroenterology Associates of Central Virginia, Lynchburg
RekryterarFas 2
Ålder 18 till 85 · Alla kön · Uppdaterad 22 sep. 2026 · NCT06226883

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

  • Pediatric Specialists of Virginia, Fairfax
RekryterarFas 3
Ålder 2 till 19 · Alla kön · Uppdaterad 22 sep. 2026 · NCT04844606

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

  • Carilion Children's Tanglewood Center, Roanoke
RekryterarFas 3
Ålder 2 och äldre · Alla kön · Uppdaterad 7 maj 2026 · NCT05442567

Precise Infliximab Exposure and Pharmacodynamic Control

  • Children's Specialty Group, Norfolk
RekryterarFas 2/3
Ålder 6 till 22 · Alla kön · Uppdaterad 5 maj 2026 · NCT05660746

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

  • Carilion Children's Tanglewood Center, Roanoke
RekryterarFas 3
Ålder 2 till 17 · Alla kön · Uppdaterad 5 maj 2026 · NCT04779320

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

  • Richmond VA Medical Center, Richmond
  • Gastroenterology Consultants of Southwest Virginia., Roanoke
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 27 apr. 2026 · NCT06456593

Ketogenic and Carnivore (Lion) Diets for Inflammatory Bowel Disease and Rheumatoid Arthritis

  • Resilient Roots: Functional Medicine, Charlottesville
Rekryterar
Ålder 18 till 64 · Alla kön · Uppdaterad 16 apr. 2026 · NCT07524244

A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

  • Investigational Site Number: 8400027, Richmond
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 27 mars 2026 · NCT06958536

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.